TenderDekho Logo
GEM

Open Tender for Inj Noradrenaline 4ml ampoule with 1 mg per ml,Inj Adrenaline 1 ml ampoule with 2 mg,Inj Atropine 1 in DEOGHAR, JHARKHAND

Bid Publish Date

12-Apr-2025, 11:42 am

Bid End Date

03-May-2025, 12:00 pm

Progress

RA
Issue12-Apr-2025, 11:42 am
Reverse AuctionCompleted
Award24-Aug-2025, 1:38 am
Explore all 5 tabs to view complete tender details

Quantity

42500

Category

Inj Noradrenaline 4ml ampoule with 1 mg per ml

Bid Type

Two Packet Bid

Categories 6

A tender has been published for All India Institute Of Medical Sciences (aiims) Inj Noradrenaline 4ml ampoule with 1 mg per ml, Inj Adrenaline 1 ml ampoule with 2 mg, Inj Atropine 1 ml ampoule with 1 mg, Inj Calcium gluconate in DEOGHAR, JHARKHAND. Quantity: 42500 by. Submission Deadline: 03-05-2025 12: 00: 00. Check eligibility and apply.

Additional Tender Data

Commercial Details

Tender Category

Goods

Bid To RA

No

Bid To RA Enabled

Yes

Item Category

Inj Noradrenaline 4ml ampoule with 1 mg per ml , Inj Adrenaline 1 ml ampoule with 2 mg , Inj Atropine 1 ml ampoule with 1 mg , Inj Calcium gluconate

Authority Records

MINISTRY OF HEALTH AND FAMILY WELFAREHEALTH AND FAMILY WELFARE DEPARTMENTALL INDIA INSTITUTE OF MEDICAL SCIENCES

BID & GeM Expert Consultancy

End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.

Bid Preparation GeM Registration Document Filing

Free consultation · 24h response

Documents 4

GeM-Bidding-7735281.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Bill of Quantities (BOQ) 14 Items Sign in for GEM prices

#1

Inj Noradrenaline 4ml ampoule with 1 mg per ml

As per attached Specification

5,000 nos Delivery: 30 days
#2

Inj Adrenaline 1 ml ampoule with 2 mg

As per attached Specification

2,000 nos Delivery: 30 days
#3

Inj Atropine 1 ml ampoule with 1 mg

As per attached Specification

1,000 nos Delivery: 30 days
#4

Inj Calcium gluconate 1g 100 mg per ml

As per attached Specification

500 nos Delivery: 30 days
#5

Inj KCL 40 mosmal 20 milli equivalent

As per attached Specification

1,000 nos Delivery: 30 days
#6

Inj Furosemide 20mg per 60mg

As per attached Specification

5,000 nos Delivery: 30 days
#7

Inj Hydrocrtisone 100 mg

As per attached Specification

10,000 nos Delivery: 30 days
#8

Inj Sodicumcarbonate

As per attached Specification

1,000 nos Delivery: 30 days
#9

Inj Amiodarone 150 mg

As per attached Specification

1,000 nos Delivery: 30 days
#10

Inj Xylocaine 2 percent

As per attached Specification

5,000 nos Delivery: 30 days
#11

Xylocaine Jelly

As per attached Specification

5,000 nos Delivery: 30 days
#12

Asthalin Solution in Bottle

As per attached Specification

5,000 nos Delivery: 30 days
#13

Inj Metoprolol 2.5 mg

As per attached Specification

500 nos Delivery: 30 days
#14

Inj Diltiazem

As per attached Specification

500 nos Delivery: 30 days

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

Certificate (Requested in

Reverse Auction Schedule

Completed

Start

20-Jul-2025, 11:00 am

End

21-Jul-2025, 11:00 am

Duration: 24 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Technical Results

S.No Seller Item Date Status
1
A M ENTERPRISES   Under PMA
-02-05-2025 22:48:15
2
Anugrah Pharma   Under PMA
-03-05-2025 02:21:10
3
K M ENTERPRISES   Under PMA
-03-05-2025 11:46:50
4
M/S BAJRANG MEDICAL HALL   Under PMA
-02-05-2025 20:54:40
5
M/S GAURI ENTERPRISES   Under PMA
-02-05-2025 18:13:56
6
SHRISTIMED INDIA PRIVATE LIMITED   Under PMA
-02-05-2025 20:14:40
7
SUNIL PHARMACY   Under PMA
-03-05-2025 11:36:39

Reverse Auction Results Final Prices

These are the final prices after the reverse auction event. Prices may be lower than initial bids.

Rank Seller Final Price Item
L1M/S GAURI ENTERPRISES(MII)   Under PMA Winner ₹6,04,500Item Categories : Inj Noradrenaline 4ml ampoule with 1 mg per ml,Inj Adrenaline 1 ml ampoule with 2 mg,Inj Atropine 1
L2A M ENTERPRISES (MSE,MII)   Under PMA₹11,39,300Item Categories : Inj Noradrenaline 4ml ampoule with 1 mg per ml,Inj Adrenaline 1 ml ampoule with 2 mg,Inj Atropine 1

🎉 L1 Winner

M/S GAURI ENTERPRISES(MII)   Under PMA

Final Price: ₹6,04,500

Contract / Result Documents 1

Please sign in or create an account to view contract details and download result documents.

Frequently Asked Questions

Key insights about JHARKHAND tender market

What are the eligibility requirements for participating in the EMERGENCY DRUGS tender?

The eligibility requirements for bidders include being a registered entity capable of supplying medical pharmaceutical products, with compliance to health regulations, state licensing requirements, and meeting all quality standards mandated by health authorities.

What certificates are required to participate in the EMERGENCY DRUGS tender?

Participants must submit valid certificates proving their compliance with quality standards in pharmaceuticals, along with necessary licenses and registrations that affirm their legal standing to supply the listed emergency drugs.

What are the requirements for the submission process of the EMERGENCY DRUGS bid?

The submission process requires bidders to provide both technical and financial bids through designated channels. Documentation should ensure compliance with all requirements outlined in the tender, accompanied by the Earnest Money Deposit (EMD) as a guarantee of bid integrity.

What are the payment terms and price evaluation criteria for the EMERGENCY DRUGS tender?

Payment terms will be outlined in the tender documentation, typically defining conditions for releasing funds upon successful delivery and acceptance of supplies. The price evaluation criteria will assess cost-effectiveness alongside compliance with technical specifications and quality assurance.

Are there any benefits provided for MSEs and startups in the EMERGENCY DRUGS tender?

Yes, this tender includes specific provisions for MSEs and startups, such as reduced EMD requirements and preferential evaluation criteria to support their participation in government contracts, thereby promoting broader inclusivity in the procurement process.